Shepard William R reported other involving 2,553.779 shares of CME GROUP INC. at $0.00 for $0 on Aug 18, 2026

Other
Form 4 code J. Other acquisition or disposition. The filer must describe the transaction.
Director
DIR
Filed Sep 28, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$0Shares × reported price
Shares traded
2,553.779Common Stock Class A
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
1,067Direct
Trade date
Aug 18, 2026Other
Filed
Sep 28, 2026, 4:15 PM ET41-day reporting delay
Accession
0001212852-26-000005Code J · Transaction 230348
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Aug 18, 2026Other2,553.779$0.00$0Trade 230349
Sep 25, 2026Buy292.55$268.76$78,625.74Trade 230350
3 transaction rows in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
2 warnings
delayed filingThe filing was reported 41 calendar days after the transaction date.
ambiguous transaction codeThe transaction code is missing or represents other activity; review the filing and footnotes.

CME price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CME · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −6.9%1w ago −1.5%1d ago +1.8%
Returns since7d +2.6%30d +11%90d180d1y

Footnotes in full

F1: Reflects a change in the form of beneficial ownership from direct to indirect ownership via transfer to the Reporting Person's revocable living trust. This transaction is exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934. F2: Represents shares acquired pursuant to a broker-administered dividend reinvestment plan.